Construction of a Cohort for Pan-Vascular Disease Among Employees of Taizhou People's Hospital

Brief summary (registry, in English)

1. Participant Recruitment During the annual health check-ups for hospital staff, potential participants are recruited. Those who express interest are provided with a detailed explanation of the study's objectives, content, and procedures, and are required to sign an informed consent form. 2. Screening Phase Medical history is collected, including any previous occurrences of myocardial infarction, ischemic or hemorrhagic stroke, or history of coronary, carotid, or peripheral arterial revascularization. 3. Baseline Data Collection 1\. Health Questionnaire Survey: Collect demographic information, medical history, and data on nutrition, physical activity, and smoking habits through a questionnaire. 2\. Clinical Assessments: Conduct the following assessments for all enrolled participants: * High-sensitivity cardiac troponin I and NT-proBNP testing * Non-invasive arterial stiffness testing * Measurement of visceral and subcutaneous fat content * Fundus photography * Body composition analysis 4 Regular Follow-Up Annual follow-up for a total of 10 years. The follow-up includes: 1. . Collection of updated demographic information and medical history, as well as repeated questionnaires on nutrition, physical activity, and smoking habits. 2. . Reassessment of the following items: * High-sensitivity cardiac troponin I and NT-proBNP testing * Non-invasive arterial stiffness testing * Measurement of visceral and subcutaneous fat content * Fundus photography * Body composition analysis 5 Outcome Evaluation 1）. Primary Outcomes: Cardiovascular mortality, non-fatal myocardial infarction, or non-fatal stroke events. 2）. Secondary Outcomes: All vascular events, changes in cardiovascular biomarkers, and degree of arterial stiffness.

What you commit to

• Study type: Observational
• Planned participants: 1000
• From 1 Sept 2024 to the primary completion date, 1 Sept 2034
• No sites listed in no country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 45 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov